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ABSTRACT 
In this thesis we have identified mechanisms involved in the exocytosis of different adiponectin 
molecular forms in health and in metabolic disease. We have also studied similarities and 
differences in depot-specific adipocyte adiponectin release. In paper I we show that the 
physiological regulation of subcutaneous white adipocyte adiponectin exocytosis involves 
β3 adrenergic receptors (β3ARs) and Exchange Protein directly Activated by cAMP isoform 1 
(Epac1) signalling. Furthermore, we show that adiponectin secretion is disturbed in obesity/type 
2 diabetes induced catecholamine resistance due to reduced abundance of the key proteins 
β3ARs and Epac1. This condition of catecholamine resistance is further associated with a ~50% 
reduction of circulating high-molecular weight (HMW) adiponectin. In paper II we show that 
β3AR-activation rapidly triggers the release of HMW adiponectin-containing vesicle whereas 
insulin induces release of smaller molecular forms, with delayed time-kinetics. We moreover 
demonstrate that both catecholamine-triggered exocytosis of HMW adiponectin and the insulin-
induced secretion of smaller adiponectin forms is entirely diminished in adipocytes from 
obese/type 2 diabetic mice. The equivalent regulation of secretion of different adiponectin 
molecular forms by catecholamines and insulin was confirmed in human adipocytes, thus 
defining a novel role of β3ARs in human adipocyte function. In paper III we propose that 
adiponectin exocytosis is regulated by sympathetic nerve endings, co-releasing noradrenaline 
and ATP within the adipose tissue. Secretion measurements confirmed that noradrenaline 
(elevates cAMP), like adrenaline in paper I, triggers adiponectin exocytosis. Extracellular ATP 
was shown to augment the exocytotic process, largely due to its elevation of intracellular Ca2+. 
We also show that defect purinergic signalling together with reduced white adipose tissue 
noradrenaline content likely aggravates the catecholamine resistance observed in paper I and II. 
Finally we describe regulation of mouse visceral adipocyte adiponectin secretion in paper IV. 
As demonstrated in subcutaneous adipocytes (paper I-III), visceral adipocyte adiponectin 
secretion is also stimulated by activation of β3AR and Epac1. In obese/diabetic conditions, 
visceral adipocytes are likewise unresponsive to stimulation with catecholamines, but the 
underlying molecular defect does not involve reduced levels of neither β3AR nor Epac1, thus 
differing from observations in subcutaneous adipocytes. In conclusion, our results suggest that 
secretory defects in obesity/type 2 diabetes, attributed to catecholamine resistance, underlie the 
reduced levels of HMW adiponectin in metabolic disease.                                                                                                                              
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